The Launch Strategy Choices in China's Pharmaceutical Market

Research output: Contribution to journalArticlepeer-review


Purpose: This paper aims to study the drug launch strategies and their effects on new drug performance in an intensely competitive emerging pharmaceutical market such as the one in China. Design/methodology/approach: Data on market share, sales, related firm size and annual profit were obtained for the period, 2004-2008. Profile deviation and cluster analysis approaches were applied in this study. Findings: There is a significant effect of an optimal launch strategy on new drug performance given the respective resource availability and the market environment situations. Practical implications: The study suggests that multi-national corporations may prove resilient in the emerging economies through both innovative and cost-driven offerings in different therapeutic categories. Originality/value: This research is unique in studying the drug launch strategies across both foreign firms and local firms in a competitive emerging pharmaceutical market.

Original languageEnglish
Pages (from-to)339 - 356
Number of pages18
JournalInternational Journal of Pharmaceutical and Healthcare Marketing
Issue number3
StatePublished - Sep 5 2016


  • China pharmaceutical industry
  • Competitive environment
  • Launch strategy
  • New drug performance
  • Resource availability


Dive into the research topics of 'The Launch Strategy Choices in China's Pharmaceutical Market'. Together they form a unique fingerprint.

Cite this